Clearwater Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Buy |
1,134
+6
| +0.5% | +$4.68K | 0.08% | 81 |
|
|
2025
Q1 | $932K | Sell |
1,128
-8
| -0.7% | -$6.61K | 0.09% | 79 |
|
|
2024
Q4 | $877K | Hold |
1,136
| – | – | 0.09% | 82 |
|
|
2024
Q3 | $1.01M | Buy |
1,136
+91
| +9% | +$80.6K | 0.1% | 76 |
|
|
2024
Q2 | $946K | Sell |
1,045
-120
| -10% | -$109K | 0.1% | 73 |
|
|
2024
Q1 | $906K | Sell |
1,165
-37
| -3% | -$28.8K | 0.1% | 71 |
|
|
2023
Q4 | $701K | Buy |
1,202
+15
| +1% | +$8.74K | 0.08% | 78 |
|
|
2023
Q3 | $638K | Sell |
1,187
-60
| -5% | -$32.2K | 0.08% | 71 |
|
|
2023
Q2 | $585K | Buy |
1,247
+10
| +0.8% | +$4.69K | 0.07% | 83 |
|
|
2023
Q1 | $425K | Sell |
1,237
-264
| -18% | -$90.7K | 0.05% | 97 |
|
|
2022
Q4 | $549K | Buy |
1,501
+52
| +4% | +$19K | 0.07% | 90 |
|
|
2022
Q3 | $469K | Buy |
1,449
+20
| +1% | +$6.47K | 0.06% | 96 |
|
|
2022
Q2 | $463K | Hold |
1,429
| – | – | 0.06% | 96 |
|
|
2022
Q1 | $409K | Sell |
1,429
-7
| -0.5% | -$2K | 0.05% | 112 |
|
|
2021
Q4 | $397K | Buy |
1,436
+111
| +8% | +$30.7K | 0.04% | 117 |
|
|
2021
Q3 | $306K | Hold |
1,325
| – | – | 0.04% | 131 |
|
|
2021
Q2 | $304K | Hold |
1,325
| – | – | 0.04% | 135 |
|
|
2021
Q1 | $248K | Hold |
1,325
| – | – | 0.03% | 146 |
|
|
2020
Q4 | $224K | Buy |
+1,325
| New | +$224K | 0.03% | 142 |
|
|
2018
Q2 | – | Sell |
-30
| Closed | -$2K | – | 400 |
|
|
2018
Q1 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 598 |
|